Longitudinal Characterization of Respiratory Tract Exacerbations and Treatment Responses in Primary Ciliary Dyskinesia

Key facts

Sponsor

University of North Carolina, Chapel Hill

Principal Investigator

Margaret Rosenfeld, MD

Seattle Children's Hospital

Enrollment

105 enrolled

Eligibility

6 years · All sexes

Timeline

2022 – 2025

Study locations (7)

• Stanford University, Palo Alto, California, United States
• Children's Hospital Colorado, Aurora, Colorado, United States
• Washington University in St. Louis, St Louis, Missouri, United States
• University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
• Seattle Children's Hospital, Seattle, Washington, United States
• The Hospital for Sick Children, Toronto, Ontario, Canada
• McGill University, Montreal, Quebec, Canada

Collaborators

Washington University School of Medicine · Children's Hospital Colorado · Stanford University · Seattle Children's Hospital · The Hospital for Sick Children · McGill University · Children's Hospital Medical Center, Cincinnati

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Primary ciliary dyskinesia

Additional recruiting or active studies for the same condition.

• RECRUITINGNANCT06959251
  Glycine and Magnesium+Thiamine for the Treatment of Primary Ciliary Dyskinesia
  Instituto Nacional de Enfermedades Respiratorias
• RECRUITINGNANCT07029594
  Thermal Spa Treatment and Improvement of Primary Ciliary Dyskinesia
  Association Francaise pour la Recherche Thermale
• RECRUITINGNCT07357558
  A Qualitative Study Investigating the Lived Experiences and Impact of Reproductive Issues in Adults With Primary Ciliary Dyskinesia
  University Hospital Southampton NHS Foundation Trust
• RECRUITINGNCT05889013
  Utility of PCD Diagnostics to Improve Clinical Care
  Connecticut Children's Medical Center
• ACTIVE NOT RECRUITINGNCT06172374
  A Study Providing Genetic Testing to Find Those Who May Have Primary Ciliary Dyskinesia for Potential Clinical Trials
  ReCode Therapeutics
• RECRUITINGNANCT07288827
  Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia
  Indiana University
• RECRUITINGNCT05287022
  Use of Nasal Nitric Oxide Testing in Improving Primary Ciliary Dyskinesia Clinical Care
  Arkansas Children's Hospital Research Institute
• RECRUITINGNANCT01929356
  Chest Physiotherapy and Lung Function in Primary Ciliary Dyskinesia
  Universitaire Ziekenhuizen KU Leuven

See all trials for Primary ciliary dyskinesia →